Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Oncology Biosimilars market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Oncology Biosimilars market. Detailed analysis of key players, along with key growth strategies adopted by Oncology Biosimilars industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Teva Pharmaceutical Industries Ltd
Apotex
Biocon
Dr. Reddy’s Laboratories
Intas Pharmaceuticals
Celltrion
Pfizer
BIOCAD
Dr Reddy’s Laboratories
STADA Arzneimittel AG
By Type:
mAb
Immunomodulators
Hematopoietic Agents
G-CSF
Others
By End-User:
Retail Pharmacies
Hospital Pharmacy
Online Pharmacy
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Biosimilars Market
-
1.3 Market Segment by Type
1.3.1 Japan Oncology Biosimilars Market Size and Growth Rate of mAb from 2014 to 2026
1.3.2 Japan Oncology Biosimilars Market Size and Growth Rate of Immunomodulators from 2014 to 2026
1.3.3 Japan Oncology Biosimilars Market Size and Growth Rate of Hematopoietic Agents from 2014 to 2026
1.3.4 Japan Oncology Biosimilars Market Size and Growth Rate of G-CSF from 2014 to 2026
1.3.5 Japan Oncology Biosimilars Market Size and Growth Rate of Others from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Oncology Biosimilars Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026
1.4.2 Japan Oncology Biosimilars Market Size and Growth Rate of Hospital Pharmacy from 2014 to 2026
1.4.3 Japan Oncology Biosimilars Market Size and Growth Rate of Online Pharmacy from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Oncology Biosimilars Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Oncology Biosimilars by Major Types
3.4.1 Market Size and Growth Rate of mAb
3.4.2 Market Size and Growth Rate of Immunomodulators
3.4.3 Market Size and Growth Rate of Hematopoietic Agents
3.4.4 Market Size and Growth Rate of G-CSF
3.4.5 Market Size and Growth Rate of Others
4 Segmentation of Oncology Biosimilars Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Oncology Biosimilars by Major End-Users
4.4.1 Market Size and Growth Rate of Oncology Biosimilars in Retail Pharmacies
4.4.2 Market Size and Growth Rate of Oncology Biosimilars in Hospital Pharmacy
4.4.3 Market Size and Growth Rate of Oncology Biosimilars in Online Pharmacy
5 Market Analysis by Regions
-
5.1 Japan Oncology Biosimilars Production Analysis by Regions
-
5.2 Japan Oncology Biosimilars Consumption Analysis by Regions
6 Hokkaido Oncology Biosimilars Landscape Analysis
-
6.1 Hokkaido Oncology Biosimilars Landscape Analysis by Major Types
-
6.2 Hokkaido Oncology Biosimilars Landscape Analysis by Major End-Users
7 Tohoku Oncology Biosimilars Landscape Analysis
-
7.1 Tohoku Oncology Biosimilars Landscape Analysis by Major Types
-
7.2 Tohoku Oncology Biosimilars Landscape Analysis by Major End-Users
8 Kanto Oncology Biosimilars Landscape Analysis
-
8.1 Kanto Oncology Biosimilars Landscape Analysis by Major Types
-
8.2 Kanto Oncology Biosimilars Landscape Analysis by Major End-Users
9 Chubu Oncology Biosimilars Landscape Analysis
-
9.1 Chubu Oncology Biosimilars Landscape Analysis by Major Types
-
9.2 Chubu Oncology Biosimilars Landscape Analysis by Major End-Users
10 Kinki Oncology Biosimilars Landscape Analysis
-
10.1 Kinki Oncology Biosimilars Landscape Analysis by Major Types
-
10.2 Kinki Oncology Biosimilars Landscape Analysis by Major End-Users
11 Chugoku Oncology Biosimilars Landscape Analysis
-
11.1 Chugoku Oncology Biosimilars Landscape Analysis by Major Types
-
11.2 Chugoku Oncology Biosimilars Landscape Analysis by Major End-Users
12 Shikoku Oncology Biosimilars Landscape Analysis
-
12.1 Shikoku Oncology Biosimilars Landscape Analysis by Major Types
-
12.2 Shikoku Oncology Biosimilars Landscape Analysis by Major End-Users
13 Kyushu Oncology Biosimilars Landscape Analysis
-
13.1 Kyushu Oncology Biosimilars Landscape Analysis by Major Types
-
13.2 Kyushu Oncology Biosimilars Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Teva Pharmaceutical Industries Ltd
14.1.1 Teva Pharmaceutical Industries Ltd Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Apotex
14.2.1 Apotex Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Biocon
14.3.1 Biocon Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Dr. Reddy’s Laboratories
14.4.1 Dr. Reddy’s Laboratories Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Intas Pharmaceuticals
14.5.1 Intas Pharmaceuticals Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Celltrion
14.6.1 Celltrion Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Pfizer
14.7.1 Pfizer Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 BIOCAD
14.8.1 BIOCAD Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Dr Reddy’s Laboratories
14.9.1 Dr Reddy’s Laboratories Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 STADA Arzneimittel AG
14.10.1 STADA Arzneimittel AG Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
The List of Tables and Figures (Totals 110 Figures and 131 Tables)
Figure Japan Oncology Biosimilars Market Size and Growth Rate of mAb from 2014 to 2026
Figure Japan Oncology Biosimilars Market Size and Growth Rate of Immunomodulators from 2014 to 2026
Figure Japan Oncology Biosimilars Market Size and Growth Rate of Hematopoietic Agents from 2014 to 2026
Figure Japan Oncology Biosimilars Market Size and Growth Rate of G-CSF from 2014 to 2026
Figure Japan Oncology Biosimilars Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Oncology Biosimilars Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026
Figure Japan Oncology Biosimilars Market Size and Growth Rate of Hospital Pharmacy from 2014 to 2026
Figure Japan Oncology Biosimilars Market Size and Growth Rate of Online Pharmacy from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Oncology Biosimilars Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Oncology Biosimilars
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Oncology Biosimilars by Different Types from 2014 to 2026
-
Table Consumption Share of Oncology Biosimilars by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of mAb
Figure Market Size and Growth Rate of Immunomodulators
Figure Market Size and Growth Rate of Hematopoietic Agents
Figure Market Size and Growth Rate of G-CSF
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Oncology Biosimilars by Different End-Users from 2014 to 2026
-
Table Consumption Share of Oncology Biosimilars by Different End-Users from 2014 to 2026
Figure Japan Oncology Biosimilars Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026
Figure Japan Oncology Biosimilars Market Size and Growth Rate of Hospital Pharmacy from 2014 to 2026
Figure Japan Oncology Biosimilars Market Size and Growth Rate of Online Pharmacy from 2014 to 2026
-
Table Japan Oncology Biosimilars Production by Regions
-
Table Japan Oncology Biosimilars Production Share by Regions
-
Figure Japan Oncology Biosimilars Production Share by Regions in 2014
-
Figure Japan Oncology Biosimilars Production Share by Regions in 2018
-
Figure Japan Oncology Biosimilars Production Share by Regions in 2026
-
Table Japan Oncology Biosimilars Consumption by Regions
-
Table Japan Oncology Biosimilars Consumption Share by Regions
-
Figure Japan Oncology Biosimilars Consumption Share by Regions in 2014
-
Figure Japan Oncology Biosimilars Consumption Share by Regions in 2018
-
Figure Japan Oncology Biosimilars Consumption Share by Regions in 2026
-
Table Hokkaido Oncology Biosimilars Consumption by Types from 2014 to 2026
-
Table Hokkaido Oncology Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Oncology Biosimilars Consumption Share by Types in 2014
-
Figure Hokkaido Oncology Biosimilars Consumption Share by Types in 2018
-
Figure Hokkaido Oncology Biosimilars Consumption Share by Types in 2026
-
Table Hokkaido Oncology Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Oncology Biosimilars Consumption Share by End-Users in 2014
-
Figure Hokkaido Oncology Biosimilars Consumption Share by End-Users in 2018
-
Figure Hokkaido Oncology Biosimilars Consumption Share by End-Users in 2026
-
Table Tohoku Oncology Biosimilars Consumption by Types from 2014 to 2026
-
Table Tohoku Oncology Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Oncology Biosimilars Consumption Share by Types in 2014
-
Figure Tohoku Oncology Biosimilars Consumption Share by Types in 2018
-
Figure Tohoku Oncology Biosimilars Consumption Share by Types in 2026
-
Table Tohoku Oncology Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Tohoku Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Oncology Biosimilars Consumption Share by End-Users in 2014
-
Figure Tohoku Oncology Biosimilars Consumption Share by End-Users in 2018
-
Figure Tohoku Oncology Biosimilars Consumption Share by End-Users in 2026
-
Table Kanto Oncology Biosimilars Consumption by Types from 2014 to 2026
-
Table Kanto Oncology Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Kanto Oncology Biosimilars Consumption Share by Types in 2014
-
Figure Kanto Oncology Biosimilars Consumption Share by Types in 2018
-
Figure Kanto Oncology Biosimilars Consumption Share by Types in 2026
-
Table Kanto Oncology Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Kanto Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Oncology Biosimilars Consumption Share by End-Users in 2014
-
Figure Kanto Oncology Biosimilars Consumption Share by End-Users in 2018
-
Figure Kanto Oncology Biosimilars Consumption Share by End-Users in 2026
-
Table Chubu Oncology Biosimilars Consumption by Types from 2014 to 2026
-
Table Chubu Oncology Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Chubu Oncology Biosimilars Consumption Share by Types in 2014
-
Figure Chubu Oncology Biosimilars Consumption Share by Types in 2018
-
Figure Chubu Oncology Biosimilars Consumption Share by Types in 2026
-
Table Chubu Oncology Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Chubu Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Oncology Biosimilars Consumption Share by End-Users in 2014
-
Figure Chubu Oncology Biosimilars Consumption Share by End-Users in 2018
-
Figure Chubu Oncology Biosimilars Consumption Share by End-Users in 2026
-
Table Kinki Oncology Biosimilars Consumption by Types from 2014 to 2026
-
Table Kinki Oncology Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Kinki Oncology Biosimilars Consumption Share by Types in 2014
-
Figure Kinki Oncology Biosimilars Consumption Share by Types in 2018
-
Figure Kinki Oncology Biosimilars Consumption Share by Types in 2026
-
Table Kinki Oncology Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Kinki Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Oncology Biosimilars Consumption Share by End-Users in 2014
-
Figure Kinki Oncology Biosimilars Consumption Share by End-Users in 2018
-
Figure Kinki Oncology Biosimilars Consumption Share by End-Users in 2026
-
Table Chugoku Oncology Biosimilars Consumption by Types from 2014 to 2026
-
Table Chugoku Oncology Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Oncology Biosimilars Consumption Share by Types in 2014
-
Figure Chugoku Oncology Biosimilars Consumption Share by Types in 2018
-
Figure Chugoku Oncology Biosimilars Consumption Share by Types in 2026
-
Table Chugoku Oncology Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Chugoku Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Oncology Biosimilars Consumption Share by End-Users in 2014
-
Figure Chugoku Oncology Biosimilars Consumption Share by End-Users in 2018
-
Figure Chugoku Oncology Biosimilars Consumption Share by End-Users in 2026
-
Table Shikoku Oncology Biosimilars Consumption by Types from 2014 to 2026
-
Table Shikoku Oncology Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Oncology Biosimilars Consumption Share by Types in 2014
-
Figure Shikoku Oncology Biosimilars Consumption Share by Types in 2018
-
Figure Shikoku Oncology Biosimilars Consumption Share by Types in 2026
-
Table Shikoku Oncology Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Shikoku Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Oncology Biosimilars Consumption Share by End-Users in 2014
-
Figure Shikoku Oncology Biosimilars Consumption Share by End-Users in 2018
-
Figure Shikoku Oncology Biosimilars Consumption Share by End-Users in 2026
-
Table Kyushu Oncology Biosimilars Consumption by Types from 2014 to 2026
-
Table Kyushu Oncology Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Oncology Biosimilars Consumption Share by Types in 2014
-
Figure Kyushu Oncology Biosimilars Consumption Share by Types in 2018
-
Figure Kyushu Oncology Biosimilars Consumption Share by Types in 2026
-
Table Kyushu Oncology Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Kyushu Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Oncology Biosimilars Consumption Share by End-Users in 2014
-
Figure Kyushu Oncology Biosimilars Consumption Share by End-Users in 2018
-
Figure Kyushu Oncology Biosimilars Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd
Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd
Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd
Table Company Profile and Development Status of Apotex
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apotex
Figure Sales and Growth Rate Analysis of Apotex
Figure Revenue and Market Share Analysis of Apotex
Table Product and Service Introduction of Apotex
Table Company Profile and Development Status of Biocon
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon
Figure Sales and Growth Rate Analysis of Biocon
Figure Revenue and Market Share Analysis of Biocon
Table Product and Service Introduction of Biocon
Table Company Profile and Development Status of Dr. Reddy’s Laboratories
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr. Reddy’s Laboratories
Figure Sales and Growth Rate Analysis of Dr. Reddy’s Laboratories
Figure Revenue and Market Share Analysis of Dr. Reddy’s Laboratories
Table Product and Service Introduction of Dr. Reddy’s Laboratories
Table Company Profile and Development Status of Intas Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intas Pharmaceuticals
Figure Sales and Growth Rate Analysis of Intas Pharmaceuticals
Figure Revenue and Market Share Analysis of Intas Pharmaceuticals
Table Product and Service Introduction of Intas Pharmaceuticals
Table Company Profile and Development Status of Celltrion
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion
Figure Sales and Growth Rate Analysis of Celltrion
Figure Revenue and Market Share Analysis of Celltrion
Table Product and Service Introduction of Celltrion
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of BIOCAD
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOCAD
Figure Sales and Growth Rate Analysis of BIOCAD
Figure Revenue and Market Share Analysis of BIOCAD
Table Product and Service Introduction of BIOCAD
Table Company Profile and Development Status of Dr Reddy’s Laboratories
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy’s Laboratories
Figure Sales and Growth Rate Analysis of Dr Reddy’s Laboratories
Figure Revenue and Market Share Analysis of Dr Reddy’s Laboratories
Table Product and Service Introduction of Dr Reddy’s Laboratories
Table Company Profile and Development Status of STADA Arzneimittel AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of STADA Arzneimittel AG
Figure Sales and Growth Rate Analysis of STADA Arzneimittel AG
Figure Revenue and Market Share Analysis of STADA Arzneimittel AG
Table Product and Service Introduction of STADA Arzneimittel AG
-
